Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

"The present results indicate that direct anti-tumor effect of ABS on pristane-induced PCT and significantly
increased survival. This hypothesis needs to now be further investigated in clinical trials."